Interview with Nadya Swart of BizNews, Nov. 1
Congratulations, John–you have really outdone yourself this time! You sure have a commitment to service. I don’t disagree. But who have you been serving? And Nuremberg 2.0 awaits. One more co-conspirator named in this blog. School of Pharmacy Alumnus Elected to National Academy of Medicine October 21, 2021 Retired Col. John D. Grabenstein, R.Ph., Ph.D.,…
Itching to grapple with the scientific analysis employed by the FBI? Martin Enserink and Yudhijit Bhattacharjee of Science have done the best reporting yet on the kinds of microbial forensic evidence we are likely to see. Meanwhile, Carrie Johnson reports on House and Senate Judiciary Committee oversight panels, which have proposed September hearings to investigate…
The following excerpts from today’s NY Times article point to serious failures of data collection, analysis, and commitment to safety at FDA. The failures follow lax, politically-driven regulations, which allow products to be licensed without data if they are substantially like other licensed products. There is no good guideline for how alike the products must…
The tide is turning. The origin of SARS-CoV-2 remains in question. And now the WaPo is supporting a full investigation, below. But don’t expect much from pending investigations by the WHO or a group that has constituted itself as from the Lancet. The Lancet group’s origin investigation is being led by Peter Daszac, PhD, whose…
The problem of highly restricted testing in the US The COVID-19 virus is quite deadly (mortality appears to be between 2 and 10% as discussed in my last post) though since we don’t know how many asymptomatic or mildly symptomatic cases there are, we still can’t be sure of this. Why don’t we know the…
What is the tag line? Don’t be poor in America. Healthcare is simply too expensive for a sizable number of Americans to afford, so they go without. And this is the result. True, there are more high-risk pregnancies in the US than there used to be, but that is equally true for other developed countries….